Bone marrow mesenchymal stem cell-derived microvesicles (BMSC-MVs) had an average size of ~ 410 nm. According to the MTT and LDH assays, BMSC-MV treatment reduced the U266 cell viability and mediated cytotoxic effects against them, respectively.
[Journal of Cancer Research and Clinical Oncology]